newsfilter
← Latest News
ACCESS Newswire·

TuHURA Biosciences, Inc. Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference

On-demand video webcast now available here TAMPA, FL / ACCESS Newswire / February 19, 2025 / TuHURA Biosciences, Inc. , a Phase 3 registration-stage immune-oncology company developing